Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus - Kalunian, Kenneth C.; Chatham, W. Winn; Massarotti, Elena M.; Reyes-Thomas, Joyce; Harris, Cole; Furie, Richard A.; Chitkara, Puja; Putterman, Chaim; Gross, Rachel L.; Somers, Emily C.; Kirou, Kyriakos A.; Ramsey-Goldman, Rosalind; et al. (Arthritis & rheumatology (Hoboken, N.J.), 2012)
Keywords: Adult; Aged; Aged, 80 and over; Antibodies, Anti-Idiotypic - blood; Antibodies, Antinuclear - blood; Autoimmune diseases; B-Lymphocytes - immunology; Biological and medical sciences; Biomarkers - blood; Blood Platelets - immunology; Case-Control Studies; Complement Activation - physiology; Complement C4b; Cross-Sectional Studies; Diseases of the osteoarticular system; DNA - immunology; Erythrocytes - immunology; Female; Humans; Lupus; Lupus Erythematosus, Systemic - blood; Lupus Erythematosus, Systemic - diagnosis; Male; Medical sciences; Middle Aged; Multivariate Analysis; Peptide Fragments - blood; Receptors, Complement - blood; Rheumatic diseases; Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis; Sensitivity and Specificity; Studies; Vimentin - blood; Performance evaluation; Immunopathology; Connective tissue disease; Skin disease; Systemic lupus erythematosus; Systemic disease; Rheumatology; Autoimmune disease; Activation; Diagnosis